LUNG CANCER SURGERY MARKET ANALYSIS

Regional Analysis

Lung Cancer Surgery Market Regional Insights

• North America: North America is the largest market for lung cancer surgery, accounting for a share of over 33.5% in 2023. North America, particularly the U.S and Canada, has well-established healthcare systems and access to advanced surgical techniques. There has been a strong emphasis on minimally invasive surgeries, such as video-assisted thoracoscopic surgery (VATS) and robotic-assisted surgeries, which lead to faster recovery times and reduced post-operative complications. Research and development efforts in this region have also focused on improving patient outcomes through personalized treatment approaches.
• Europe: Europe is the second-largest market for lung cancer surgery, accounting for a share of over 26.1% in 2023. European countries have been adopting innovative surgical techniques for lung cancer treatment. The emphasis on multidisciplinary care, including surgery, chemotherapy, and radiotherapy, has been prominent. The availability of specialized cancer centers and a well-connected healthcare network has contributed to the adoption of advanced surgical procedures.
• Asia Pacific: Asia Pacific is the fastest-growing market for lung cancer surgery, accounting for a share of over 20.3% in 2023. The Asia Pacific region has seen a rise in lung cancer cases due to factors like increased smoking rates, improving healthcare infrastructure, and increasing awareness about early detection. Countries like China, Japan, and South Korea have been investing in healthcare infrastructure and technology, leading to the growth of lung cancer surgeries. There’s a growing trend towards minimally invasive procedures in this region as well.

Figure 1. Global Lung Cancer Surgery Market Share (%), By Region, 2023